10 Nov 2022 , 11:53 AM
Net profit of Lincoln Pharmaceuticals rose 2.95% to Rs 23.71 crore in the quarter ended September 2022 as against Rs 23.03 crore during the previous quarter ended September 2021. Sales rose 10.31% to Rs 140.61 crore in the quarter ended September 2022 as against Rs 127.47 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 140.61 | 127.47 | 10 |
| OPM % | 20.55 | 22.95 | – |
| PBDT | 34.45 | 32.52 | 6 |
| PBT | 32.03 | 30.53 | 5 |
| NP | 23.71 | 23.03 | 3 |
Powered by Capital Market – Live News
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
